Veracyte Inc

VCYT

Equity

ISIN null / Valor 22423969

NASDAQ (2026-03-31)

USD 32.21+5.81%

Veracyte Inc
UMushroom community rating:

3.75 4 votes No rating yet

NegativeNeutralPositive

About company

Veracyte Inc is a biotechnology company that specializes in developing and commercializing molecular diagnostic tests. These tests are designed to provide actionable insights for clinicians in the diagnosis and treatment of cancer, focusing on delivering precise, personalized healthcare. Veracyte's offerings are particularly valuable at critical decision points in a patient's cancer care journey, helping to navigate the complexities of diagnosing suspicious symptoms and determining the most appropriate treatment strategies. By leveraging advanced genomic technology, Veracyte's diagnostic and prognostic tests aim to bring clarity to the diagnosis of complex diseases, enabling more informed and confident decision-making. This, in turn, helps in avoiding unnecessary medical procedures and expediting the path to the correct diagnosis and treatment, thereby improving patient outcomes. While the company also engages in environmental, social, and governance (ESG) initiatives, its core business revolves around enhancing the precision and efficiency of cancer care through its innovative diagnostic solutions.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

8.63%1Y

44.4%3Y

-40.1%5Y

Performance

52.7%1Y

52.3%3Y

64.6%5Y

Volatility